Close Menu

Betting on Biotech

Big pharma is taking big risks in its dealings with biotech, The Wall Street Journal's Jason Douglas says. Pushed by the market to get new products out, pharmaceutical companies are spending less on their own research and more on acquiring experimental compounds from biotech companies, even if they've barely begun to be tested.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.